# African American Cancer Clinical Trial Decisions: Testing Tailored Messages

> **NCT02356549** · NA · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 90 (actual)

## Conditions studied

- Myeloma
- Lymphoma
- Leukemia

## Interventions

- **BEHAVIORAL:** EMR Tailoring
- **BEHAVIORAL:** Survey Tailoring
- **BEHAVIORAL:** Physician Involvement

## Key facts

- **NCT ID:** NCT02356549
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-01
- **Primary completion:** 2020-03-06
- **Final completion:** 2020-03-06
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2020-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02356549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02356549, "African American Cancer Clinical Trial Decisions: Testing Tailored Messages". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02356549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*